The Parkview Stanley Wissman Stroke Center has contributed to stroke research since 1993, including national studies and investigations of clot-busting drugs and types of stents. Stroke center patients benefit from innovations and are able to participate in new studies.
If you are receiving care following a stroke, you may have the opportunity to receive treatment that is only available a few places in the world. New medicines, technology and medical protocols are available to individuals who meet established requirements. These opportunities are possible because the Parkview Stanley Wissman Stroke Center works closely with the Parkview Research Center ― the area’s only hospital-based clinical research facility.
Through the Parkview Research Center, individuals throughout northeast Indiana, southern Michigan and northwest Ohio can take part in significant medical studies designed to help gain U.S. Food & Drug Administration (FDA) approval for emerging ways to treat diseases and medical conditions. The research center currently has nearly 30 stroke-related clinical trials in progress, each one lasting one to five years.
There are many reasons why an individual may consider taking part in a clinical research study. Learn about current research studies on neurological conditions.
If you or someone you know is thinking about participating in a study, be informed and talk with your personal physician.